AzTrials
AzTrials

Behavior, RiskNCT03910218

Come As You Are - Assessing the Efficacy of a Nurse Case Management HIV Prevention and Care Intervention Among Homeless Youth

A study testing NCM4HIV in people with Behavior, Risk, run by The University of Texas Health Science Center, Houston at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to to determine the efficacy of the Nurse Case Management HIV (NCM4HIV) intervention on HIV prevention compared to usual care among Youth Experiencing Homelessness (YEH). Read more about this study

Who is it for?
Ages 16 to 25 years
Conditions the study is for
Behavior, Risk
What is being tested?
NCM4HIV
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
474 participants
Where
1 siteUnited States
Study dates
11 Nov 2019to 3 Apr 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 25 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • youth engaged in high-risk sexual activity or intravenous drug use
  • speak English
  • homeless
  • not planning to move out of the metro area during the study

Who cannot join

  • youth with very low literacy
  • severe acute mental symptoms

Trial locations and contacts

1 site in 1 country.

United States1 site
  • The University of Texas Health Science Center at Houston

    Houston, Texas, 77030

Other trials in United States

About this study

The purpose of this study is to to determine the efficacy of the Nurse Case Management HIV (NCM4HIV) intervention on HIV prevention compared to usual care among Youth Experiencing Homelessness (YEH).

Conditions
Behavior, Risk
Being tested
NCM4HIV, Usual Care
Keywords
HIV prevention, homeless
Medical subject headings
Risk-Taking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • NCM4HIVBehavioural

    Participant will receive NCM4HIV intervention which includes Personalized HIV prevention education, behavior goal-setting,behavioral self-monitoring, PrEP eligibility screening,PrEP/nPEP services (labs, medication), healthcare planning/coordination, MI counseling approach, assisting with cognitive appraisals (clarifying misconceptions),promoting health seeking and coping behaviors that incorporate the situational, personal, social, and resource needs affecting health

  • Usual CareBehavioural

    Participant will receive usual care which includes Housing, food, and clothing needs,health assessment, basic healthcare, limited anticipatory guidance, mental health counseling, substance use treatment referrals, PrEP/nPEP referrals

Study groups in NCT03910218
Study groupRoleWhat they receive
NCM4HIVExperimentalParticipant will receive NCM4HIV intervention which includes Personalized HIV prevention education, behavior goal-setting,behavioral self-monitoring,Pre exposure prophylaxis (PrEP) eligibility screening,PrEP/non occupational post exposure prophylaxis(nPEP)services (labs, medication), healthcare planning/coordination, Motivational Interviewing (MI) counseling approach, assisting with cognitive appraisals (clarifying misconceptions),promoting health seeking and coping behaviors that incorporate the situational, personal, social, and resource needs affecting health
Receives: Behavioral: NCM4HIV
Usual carePlacebo comparatorParticipants will receive the usual care which includes Housing, food, and clothing needs,health assessment, basic healthcare, limited anticipatory guidance, mental health counseling,substance use treatment referrals,PrEP/nPEP referrals
Receives: Behavioral: Usual Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Participants Who Use Preventive Prophylaxis (PrEP)

    Measured: baseline

  2. Number of Participants Who Use Preventive Prophylaxis (PrEP)

    Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

    Measured: At completion of the 3-month intervention (Month 3)

  3. Number of Participants Who Use Preventive Prophylaxis (PrEP)

    Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

    Measured: 3 months after intervention (Month 6)

  4. Number of Participants Who Use Preventive Prophylaxis (PrEP)

    Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

    Measured: 6 months after intervention (Month 9)

  5. Number of Participants Who Use Preventive Prophylaxis (PrEP)

    Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

    Measured: 9 months after intervention (Month 12)

  6. Number of Participants Who Use Non-occupational Post-exposure Prophylaxis (nPEP)

    Measured: baseline

  7. Number of Participants Who Use Non-occupational Post-exposure Prophylaxis (nPEP)

    Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

    Measured: At completion of the 3-month intervention (Month 3)

  8. Number of Participants Who Use Non-occupational Post-exposure Prophylaxis (nPEP)

    Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

    Measured: 3 months after intervention (Month 6)

  9. Number of Participants Who Use Non-occupational Post-exposure Prophylaxis (nPEP)

    Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

    Measured: 6 months after intervention (Month 9)

  10. Number of Participants Who Use Non-occupational Post-exposure Prophylaxis (nPEP)

    Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

    Measured: 9 months after intervention (Month 12)

  11. Number of Participants Who Use Condoms at Last Sex as Measured by the Youth Risk Behavior Survey

    An item from the Youth Risk Behavior Survey was used to assess this outcome. The items asked if a condom was used at last sex. The number of participants who answered yes is reported.

    Measured: baseline

  12. Number of Participants Who Use Condoms at Last Sex as Measured by the Youth Risk Behavior Survey

    An item from the Youth Risk Behavior Survey was used to assess this outcome. The items asked if a condom was used at last sex. The number of participants who answered yes is reported.\

    Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

    Measured: At completion of the 3-month intervention (Month 3)

  13. Number of Participants Who Use Condoms at Last Sex as Measured by the Youth Risk Behavior Survey

    An item from the Youth Risk Behavior Survey was used to assess this outcome. The items asked if a condom was used at last sex. The number of participants who answered yes is reported.

    Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

    Measured: 3 months after intervention (Month 6)

  14. Number of Participants Who Use Condoms at Last Sex as Measured by the Youth Risk Behavior Survey

    An item from the Youth Risk Behavior Survey was used to assess this outcome. The items asked if a condom was used at last sex. The number of participants who answered yes is reported.

    Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

    Measured: 6 months after intervention (Month 9)

  15. Number of Participants Who Use Condoms at Last Sex as Measured by the Youth Risk Behavior Survey

    An item from the Youth Risk Behavior Survey was used to assess this outcome. The items asked if a condom was used at last sex. The number of participants who answered yes is reported.

    Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

    Measured: 9 months after intervention (Month 12)

  16. Number of Participants Who Tested Positive for HIV or Sexually Transmitted Infection (STI)

    Sexually Transmitted Infection tested includes syphilis, chlamydia and gonorrhea.

    Measured: Baseline

  17. Number of Participants Who Tested Positive for HIV or Sexually Transmitted Infection (STI)

    Sexually Transmitted Infection tested includes syphilis, chlamydia and gonorrhea.

    Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

    Measured: At completion of the 3-month intervention (Month 3)

  18. Number of Participants Who Tested Positive for HIV or Sexually Transmitted Infection (STI)

    Sexually Transmitted Infection tested includes syphilis, chlamydia and gonorrhea.

    Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

    Measured: 3 months after intervention (Month 6)

  19. Number of Participants Who Tested Positive for HIV or Sexually Transmitted Infection (STI)

    Sexually Transmitted Infection tested includes syphilis, chlamydia and gonorrhea.

    Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

    Measured: 6 months after intervention (Month 9)

  20. Number of Participants Who Tested Positive for HIV or Sexually Transmitted Infection (STI)

    Sexually Transmitted Infection tested includes syphilis, chlamydia and gonorrhea.

    Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

    Measured: 9 months after intervention (Month 12)

Secondary outcomes (17)
  1. Mental Health as Measured by the Brief Symptom Index-18

    The Brief Symptom Inventory 18 (BSI-18) consists of 18 items on a 5-point (0-4) Likert scale and is designed to assess current psychological distress (over the past 7 days). Total score ranges from 0 to 72, with higher scores indicating greater distress.

    Measured: baseline

  2. Mental Health as Measured by the Brief Symptom Index-18

    The BSI-18 consists of 18 items on a 5-point (0-4) Likert scale and is designed to assess current psychological distress (over the past 7 days). Total score ranges from 0 to 72, with higher scores indicating greater distress.

    Measured: At completion of the 3-month intervention (Month 3)

  3. Mental Health as Measured by the Brief Symptom Index-18

    The BSI-18 consists of 18 items on a 5-point (0-4) Likert scale and is designed to assess current psychological distress (over the past 7 days). Total score ranges from 0 to 72, with higher scores indicating greater distress.

    Measured: 3 months after intervention (Month 6)

  4. Mental Health as Measured by the Brief Symptom Index-18

    The BSI-18 consists of 18 items on a 5-point (0-4) Likert scale and is designed to assess current psychological distress (over the past 7 days). Total score ranges from 0 to 72, with higher scores indicating greater distress.

    Measured: 6 months after intervention (Month 9)

  5. Mental Health as Measured by the Brief Symptom Index-18

    The BSI-18 consists of 18 items on a 5-point (0-4) Likert scale and is designed to assess current psychological distress (over the past 7 days). Total score ranges from 0 to 72, with higher scores indicating greater distress.

    Measured: 9 months after intervention (Month 12)

  6. Housing Status

    Participants will be asked if they live in a shelter, apartment/house, with someone, outside, or in a car, etc.

    Measured: baseline

  7. Housing Status

    Participants will be asked if they live in a shelter, apartment/house, with someone, outside, or in a car, etc.

    Measured: At completion of the 3-month intervention (Month 3)

  8. Housing Status

    Participants will be asked if they live in a shelter, apartment/house, with someone, outside, or in a car, etc.

    Measured: 3 months after intervention (Month 6)

  9. Housing Status

    Participants will be asked if they live in a shelter, apartment/house, with someone, outside, or in a car, etc.

    Measured: 6 months after intervention (Month 9)

  10. Housing Status

    Participants will be asked if they live in a shelter, apartment/house, with someone, outside, or in a car, etc.

    Measured: 9 months after intervention (Month 12)

  11. Number of Participants With Substance Use as Measured by Item 11 in the Texas Christian University (TCU) Drug Screen II

    An item from the Texas Christian University (TCU) drug screen II was used to assess this outcome. The item listed various drug substances and asked whether any of those listed had been used in the past 30 days. The number of participants who answered yes is reported.

    Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

    Measured: At completion of the 3-month intervention (Month 3), 3 months after intervention (Month 6), 6 months after intervention (Month 9), 9 months after intervention (Month 12)

  12. Mental Health as Measured by the Patient Health Questionnaire (PHQ-9)

    The Patient Health Questionnaire (PHQ-9) total score ranges from 0 to 27, with higher scores indicating more severe depression

    Measured: baseline

  13. Mental Health as Measured by the Patient Health Questionnaire (PHQ-9)

    The Patient Health Questionnaire (PHQ-9) total score ranges from 0 to 27, with higher scores indicating more severe depression.

    Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

    Measured: At completion of the 3-month intervention (Month 3)

  14. Mental Health as Measured by the Patient Health Questionnaire (PHQ-9)

    The Patient Health Questionnaire (PHQ-9) total score ranges from 0 to 27, with higher scores indicating more severe depression.

    Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

    Measured: 3 months after intervention (Month 6)

  15. Mental Health as Measured by the Patient Health Questionnaire (PHQ-9)

    The Patient Health Questionnaire (PHQ-9) total score ranges from 0 to 27, with higher scores indicating more severe depression.

    Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

    Measured: 6 months after intervention (Month 9)

  16. Mental Health as Measured by the Patient Health Questionnaire (PHQ-9)

    The Patient Health Questionnaire (PHQ-9) total score ranges from 0 to 27, with higher scores indicating more severe depression.

    Multiple imputation was used because there were high missing fractions for many variables. This approach assumed that data were missing at random (MAR) and the imputation model used the same multilevel modeling approach that was used for analysis. The models made use of the correlations among repeated measurements for participants to estimate missing values. The descriptive statistics represent averages across 10 imputed data sets.

    Measured: 9 months after intervention (Month 12)

  17. Number of Participants With Substance Use as Measured by Item 11 in the Texas Christian University (TCU) Drug Screen II

    An item from the Texas Christian University (TCU) drug screen II was used to assess this outcome. The item listed various drug substances and asked whether any of those listed had been used in the past 30 days. The number of participants who answered yes is reported.

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Apr 2019
  2. Study start11 Nov 2019
  3. Primary completion3 Apr 2024
  4. Study completion3 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
474 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03910218
Sponsor's protocol ID
HSC-SN-18-0993
Status last verified
Jun 2025
First submitted
8 Apr 2019
Last updated
26 Jun 2025
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Fernandez-Sanchez H, Jones J, Arandhara U, Padhye N, Nyamathi A, Lightfoot M, Quadri Y, Paul M, Businelle MS, Maria DS. Prevalence and characteristics of sex trafficking among youth experiencing homelessness: A cross-sectional study. PLoS One. 2026 Aug 26;21(8):e0357091. doi: 10.1371/journal.pone.0357091. eCollection 2026.

    PubMed 42647548
  • Maria DS, Nyamathi A, Lightfoot M, Paul M, Quadri Y, Padhye N, Businelle M, Fernandez-Sanchez H, Jones JT. Results of a Randomized Wait-List Controlled Trial of CAYA: A Nurse Case Management HIV Prevention Intervention for Youth Experiencing Homelessness. AIDS Behav. 2025 Feb;29(2):613-625. doi: 10.1007/s10461-024-04544-3. Epub 2024 Nov 12.

    PubMed 39531116
  • Santa Maria DM, Padhye N, Ostrosky-Zeichner L, Grimes CZ, Nyamathi A, Lightfoot M, Quadri Y, Paul ME, Jones JT. COVID-19 Vaccination Uptake, Infection Rates, and Seropositivity Among Youth Experiencing Homelessness in the United States. Nurs Res. 2024 Sep-Oct 01;73(5):373-380. doi: 10.1097/NNR.0000000000000747. Epub 2024 May 10.

    PubMed 38809559

Questions about this trial

What is this clinical trial studying?

A study testing NCM4HIV in people with Behavior, Risk, run by The University of Texas Health Science Center, Houston at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 26 Jun 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Participants Who Use Preventive Prophylaxis (PrEP) (time frame: baseline). The study lists 20 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03910218, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in